Cefepime‐induced encephalopathy: Neural mass modeling of triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC)

Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. Methods...

Full description

Saved in:
Bibliographic Details
Published inPsychiatry and clinical neurosciences Vol. 73; no. 1; pp. 34 - 42
Main Authors Tamune, Hidetaka, Hamamoto, Yu, Aso, Naofumi, Yamamoto, Naoki
Format Journal Article
LanguageEnglish
Published Melbourne John Wiley & Sons Australia, Ltd 01.01.2019
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. Methods CIE cases documented by a single‐center consultation–liaison team between April 2015 and March 2017 were retrospectively reviewed. For further investigation, neural mass modeling was performed in silico. Results Three patients with CIE refused medication/examination and showed overt pain, palilalia, and much greater deterioration of eye and verbal response than the motor response, which was possibly related to GABAergic dysfunction. Triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC) were identified on the EEG of all three cases. The simulation reproduced the characteristic feature of 2–3 Hz Tri‐HNC and recovery course on EEG, and a possible involvement of individual differences in pharmacological intervention. It also suggested that auto‐inhibition (synaptic inputs from interneuron to interneuron) dysregulation contributed to generating Tri‐HNC in CIE. Conclusion As CIE is iatrogenic and continues unless cefepime is stopped, early recognition is crucial. Physicians should be vigilant about altered mental status, pain, and verbal changes in patients taking cefepime. Tri‐HNC on EEG can expedite the diagnosis of CIE, and the association between Tri‐HNC and CIE suggests that an excitatory and inhibitory imbalance due to the dysfunction of GABAergic interneurons is the underlying mechanism. This modeling may offer a new method of investigating disorders related to GABAergic dysfunction.
AbstractList AIMCefepime, a fourth-generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime-induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. METHODSCIE cases documented by a single-center consultation-liaison team between April 2015 and March 2017 were retrospectively reviewed. For further investigation, neural mass modeling was performed in silico. RESULTSThree patients with CIE refused medication/examination and showed overt pain, palilalia, and much greater deterioration of eye and verbal response than the motor response, which was possibly related to GABAergic dysfunction. Triphasic wave-like generalized periodic discharges with a high negative component (Tri-HNC) were identified on the EEG of all three cases. The simulation reproduced the characteristic feature of 2-3 Hz Tri-HNC and recovery course on EEG, and a possible involvement of individual differences in pharmacological intervention. It also suggested that auto-inhibition (synaptic inputs from interneuron to interneuron) dysregulation contributed to generating Tri-HNC in CIE. CONCLUSIONAs CIE is iatrogenic and continues unless cefepime is stopped, early recognition is crucial. Physicians should be vigilant about altered mental status, pain, and verbal changes in patients taking cefepime. Tri-HNC on EEG can expedite the diagnosis of CIE, and the association between Tri-HNC and CIE suggests that an excitatory and inhibitory imbalance due to the dysfunction of GABAergic interneurons is the underlying mechanism. This modeling may offer a new method of investigating disorders related to GABAergic dysfunction.
Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. Methods CIE cases documented by a single‐center consultation–liaison team between April 2015 and March 2017 were retrospectively reviewed. For further investigation, neural mass modeling was performed in silico. Results Three patients with CIE refused medication/examination and showed overt pain, palilalia, and much greater deterioration of eye and verbal response than the motor response, which was possibly related to GABAergic dysfunction. Triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC) were identified on the EEG of all three cases. The simulation reproduced the characteristic feature of 2–3 Hz Tri‐HNC and recovery course on EEG, and a possible involvement of individual differences in pharmacological intervention. It also suggested that auto‐inhibition (synaptic inputs from interneuron to interneuron) dysregulation contributed to generating Tri‐HNC in CIE. Conclusion As CIE is iatrogenic and continues unless cefepime is stopped, early recognition is crucial. Physicians should be vigilant about altered mental status, pain, and verbal changes in patients taking cefepime. Tri‐HNC on EEG can expedite the diagnosis of CIE, and the association between Tri‐HNC and CIE suggests that an excitatory and inhibitory imbalance due to the dysfunction of GABAergic interneurons is the underlying mechanism. This modeling may offer a new method of investigating disorders related to GABAergic dysfunction.
Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABA A receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. Methods CIE cases documented by a single‐center consultation–liaison team between April 2015 and March 2017 were retrospectively reviewed. For further investigation, neural mass modeling was performed in silico. Results Three patients with CIE refused medication/examination and showed overt pain, palilalia, and much greater deterioration of eye and verbal response than the motor response, which was possibly related to GABAergic dysfunction. Triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC) were identified on the EEG of all three cases. The simulation reproduced the characteristic feature of 2–3 Hz Tri‐HNC and recovery course on EEG, and a possible involvement of individual differences in pharmacological intervention. It also suggested that auto‐inhibition (synaptic inputs from interneuron to interneuron) dysregulation contributed to generating Tri‐HNC in CIE. Conclusion As CIE is iatrogenic and continues unless cefepime is stopped, early recognition is crucial. Physicians should be vigilant about altered mental status, pain, and verbal changes in patients taking cefepime. Tri‐HNC on EEG can expedite the diagnosis of CIE, and the association between Tri‐HNC and CIE suggests that an excitatory and inhibitory imbalance due to the dysfunction of GABAergic interneurons is the underlying mechanism. This modeling may offer a new method of investigating disorders related to GABAergic dysfunction.
Cefepime, a fourth-generation cephalosporin, acts as a GABA receptor antagonist. Cefepime-induced encephalopathy (CIE) is frequently overlooked. We aimed to clarify the clinical features, characteristic electroencephalography (EEG), and mechanisms of CIE to aid in its early recognition. CIE cases documented by a single-center consultation-liaison team between April 2015 and March 2017 were retrospectively reviewed. For further investigation, neural mass modeling was performed in silico. Three patients with CIE refused medication/examination and showed overt pain, palilalia, and much greater deterioration of eye and verbal response than the motor response, which was possibly related to GABAergic dysfunction. Triphasic wave-like generalized periodic discharges with a high negative component (Tri-HNC) were identified on the EEG of all three cases. The simulation reproduced the characteristic feature of 2-3 Hz Tri-HNC and recovery course on EEG, and a possible involvement of individual differences in pharmacological intervention. It also suggested that auto-inhibition (synaptic inputs from interneuron to interneuron) dysregulation contributed to generating Tri-HNC in CIE. As CIE is iatrogenic and continues unless cefepime is stopped, early recognition is crucial. Physicians should be vigilant about altered mental status, pain, and verbal changes in patients taking cefepime. Tri-HNC on EEG can expedite the diagnosis of CIE, and the association between Tri-HNC and CIE suggests that an excitatory and inhibitory imbalance due to the dysfunction of GABAergic interneurons is the underlying mechanism. This modeling may offer a new method of investigating disorders related to GABAergic dysfunction.
Author Yamamoto, Naoki
Hamamoto, Yu
Aso, Naofumi
Tamune, Hidetaka
AuthorAffiliation 1 Department of Neuropsychiatry Tokyo Metropolitan Tama Medical Center Tokyo Japan
3 Department of Cellular Neurobiology, Graduate School of Medicine The University of Tokyo Tokyo Japan
4 Department of Earth and Planetary Science, Graduate School of Science The University of Tokyo Tokyo Japan
5 School of Science Tokyo Institute of Technology Tokyo Japan
2 Department of Neuropsychiatry, Graduate School of Medicine The University of Tokyo Tokyo Japan
AuthorAffiliation_xml – name: 1 Department of Neuropsychiatry Tokyo Metropolitan Tama Medical Center Tokyo Japan
– name: 3 Department of Cellular Neurobiology, Graduate School of Medicine The University of Tokyo Tokyo Japan
– name: 4 Department of Earth and Planetary Science, Graduate School of Science The University of Tokyo Tokyo Japan
– name: 5 School of Science Tokyo Institute of Technology Tokyo Japan
– name: 2 Department of Neuropsychiatry, Graduate School of Medicine The University of Tokyo Tokyo Japan
Author_xml – sequence: 1
  givenname: Hidetaka
  orcidid: 0000-0002-5581-5720
  surname: Tamune
  fullname: Tamune, Hidetaka
  email: tamune-tky@umin.ac.jp
  organization: The University of Tokyo
– sequence: 2
  givenname: Yu
  surname: Hamamoto
  fullname: Hamamoto, Yu
  organization: The University of Tokyo
– sequence: 3
  givenname: Naofumi
  surname: Aso
  fullname: Aso, Naofumi
  organization: Tokyo Institute of Technology
– sequence: 4
  givenname: Naoki
  surname: Yamamoto
  fullname: Yamamoto, Naoki
  organization: Tokyo Metropolitan Tama Medical Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30375126$$D View this record in MEDLINE/PubMed
BookMark eNp1kctu1DAYhS1URC-w4AWQJTbtIq0vkxsLJBQBRaoGFmVteZw_iUtiBzuZ0bDqI3TP2_Ek_MOUCpDwJpby6dM5PsfkwHkHhDzn7JzjuRiNO-ciL9NH5IgvFizhBS8P8C6FTLjk2SE5jvGGMSZlxp-QQ8lknnKRHZHvFTQw2gF-3N5ZV88GagrOwNjp3o966rav6BLmoHs66Bjp4GvorWupb-gULGLRGrrR652gt1-AtuAAcfsNTSME62sEahtNp0MLkW7s1FFNO9t21EGrJ7sGavwwYic30dPrYFF1uazOnpLHje4jPLv_npDP795eV5fJ1cf3H6o3V4lJOU-TspEZmFJnuhSF5EIamYtFVtSpMIZnohErnkLBhBSs0I00kK7YIs0kE7VIcy5PyOu9d5xXA9QGY2ABNQY76LBVXlv19x9nO9X6tcolvrksUXB6Lwj-6wxxUgP2hb7XDvwclcBxeFmKPEX05T_ojZ-Dw3pI7SJlpWBIne0pE3yMAZqHMJyp3eQKJ1e_Jkf2xZ_pH8jfGyNwsQc2toft_03qU7XcK38C2kq8JQ
CitedBy_id crossref_primary_10_1002_npr2_12427
crossref_primary_10_1097_WNP_0000000000000764
crossref_primary_10_2131_jts_47_429
crossref_primary_10_1002_mds_27855
crossref_primary_10_1097_WNP_0000000000000809
crossref_primary_10_1016_j_jiac_2020_05_011
crossref_primary_10_1007_s40278_019_57725_9
Cites_doi 10.1016/j.ensci.2017.08.001
10.1016/S0002-9343(01)00767-7
10.1002/ana.410100502
10.1186/s13054-017-1856-1
10.1016/j.clinph.2017.06.245
10.1016/j.clinph.2015.07.018
10.1146/annurev-pharmtox-010611-134636
10.1097/WNP.0b013e3182a73e16
10.1038/44579
10.1007/s12028-008-9166-8
10.1212/WNL.0000000000002023
10.1097/WNP.0b013e31826bde70
10.1093/ndt/gfm713
10.1136/jnnp.63.3.279
10.1038/nn.3950
10.1186/cc13094
10.1016/S0987-7053(00)00234-3
10.1016/j.expneurol.2016.05.037
10.1345/aph.1L307
10.1523/JNEUROSCI.23-29-09664.2003
10.1016/j.clinph.2013.08.005
10.1212/WNL.0000000000002455
10.1016/S0028-3908(03)00188-6
10.1212/WNL.54.11.2153
10.1592/phco.23.3.369.32100
10.1080/net.13.1.67.113
10.1111/j.1528-1167.2005.16305.x
10.1530/EDM-17-0010
10.1016/j.biopsych.2017.05.024
10.1016/j.yebeh.2015.04.007
ContentType Journal Article
Copyright 2018 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology
2018 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
2019 The Author. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology
2018 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology
Copyright_xml – notice: 2018 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology
– notice: 2018 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
– notice: 2019 The Author. Psychiatry and Clinical Neurosciences © 2019 Japanese Society of Psychiatry and Neurology
– notice: 2018 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology
DBID 24P
WIN
NPM
AAYXX
CITATION
7TK
K9.
7X8
5PM
DOI 10.1111/pcn.12795
DatabaseName Wiley Online Library
Wiley-Blackwell Open Access Backfiles
PubMed
CrossRef
Neurosciences Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Neurosciences Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
ProQuest Health & Medical Complete (Alumni)
PubMed
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Cefepime encephalopathy and Tri‐HNC
EISSN 1440-1819
EndPage 42
ExternalDocumentID 10_1111_pcn_12795
30375126
PCN12795
Genre article
Journal Article
GroupedDBID ---
.3N
.55
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
24P
29P
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
7.U
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIVO
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHEFC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
E3Z
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
EPS
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TKC
TR2
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
ZXP
ZZTAW
~02
~IA
~WT
NPM
AAYXX
CITATION
7TK
K9.
7X8
5PM
ID FETCH-LOGICAL-c5115-9f36ec9a6a9283123c372468d52cc162f2b15e8023208af3ce5b0456302d25713
IEDL.DBID DR2
ISSN 1323-1316
IngestDate Tue Sep 17 21:21:54 EDT 2024
Fri Aug 16 01:00:54 EDT 2024
Thu Oct 10 20:38:37 EDT 2024
Fri Aug 23 03:33:19 EDT 2024
Wed Oct 16 00:52:18 EDT 2024
Sat Aug 24 01:06:39 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords electroencephalography
computer simulation
GABAergic neurons
non-convulsive status epilepticus
encephalopathy
Language English
License Attribution-NonCommercial
2018 The Authors Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5115-9f36ec9a6a9283123c372468d52cc162f2b15e8023208af3ce5b0456302d25713
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
The copyright line for this article was changed on 15 August 2019 after original online publication.
ORCID 0000-0002-5581-5720
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpcn.12795
PMID 30375126
PQID 2163026920
PQPubID 1106347
PageCount 9
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7379539
proquest_miscellaneous_2127199275
proquest_journals_2163026920
crossref_primary_10_1111_pcn_12795
pubmed_primary_30375126
wiley_primary_10_1111_pcn_12795_PCN12795
PublicationCentury 2000
PublicationDate January 2019
PublicationDateYYYYMMDD 2019-01-01
PublicationDate_xml – month: 01
  year: 2019
  text: January 2019
PublicationDecade 2010
PublicationPlace Melbourne
PublicationPlace_xml – name: Melbourne
– name: Australia
– name: Tokyo
PublicationTitle Psychiatry and clinical neurosciences
PublicationTitleAlternate Psychiatry Clin Neurosci
PublicationYear 2019
Publisher John Wiley & Sons Australia, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons Australia, Ltd
– name: Wiley Subscription Services, Inc
References 2017; 8
2017; 82
2015; 18
1997; 63
2002; 13
2017; 21
2016; 127
1999; 401
2005; 46
2012; 52
2016; 283
2001; 111
2015; 49
2013; 17
2009; 10
2000; 54
2015; 85
2000; 30
2013; 30
2016; 86
2008; 23
2017
2012; 29
2008; 42
2014; 125
1981; 10
2017; 128
2010; 50
2003; 45
2003; 23
e_1_2_8_28_1
e_1_2_8_29_1
Shirota Y (e_1_2_8_22_1) 2012; 52
e_1_2_8_24_1
e_1_2_8_25_1
e_1_2_8_26_1
e_1_2_8_27_1
Kobayakawa Y (e_1_2_8_31_1) 2010; 50
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_23_1
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – year: 2017
  article-title: GAD antibody‐associated limbic encephalitis in a young woman with APECED
  publication-title: Endocrinol. Diabetes Metab. Case Rep.
– volume: 401
  start-page: 796
  year: 1999
  end-page: 800
  article-title: Benzodiazepine actions mediated by specific gamma‐aminobutyric acid(A) receptor subtypes
  publication-title: Nature
– volume: 52
  start-page: 111
  year: 2012
  end-page: 133
  article-title: Chronic pain states: Pharmacological strategies to restore diminished inhibitory spinal pain control
  publication-title: Annu. Rev. Pharmacol. Toxicol.
– volume: 283
  start-page: 57
  year: 2016
  end-page: 72
  article-title: Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome
  publication-title: Exp. Neurol.
– volume: 52
  start-page: 356
  year: 2012
  end-page: 359
  article-title: Severely abnormal electroencephalogram in two patients who were treated with cefepime
  publication-title: Clin. Neurol.
– volume: 23
  start-page: 369
  year: 2003
  end-page: 373
  article-title: Retrospective review of neurotoxicity induced by cefepime and ceftazidime
  publication-title: Pharmacotherapy
– volume: 30
  start-page: 383
  year: 2000
  end-page: 386
  article-title: Severe but reversible encephalopathy associated with cefepime
  publication-title: Neurophysiol. Clin.
– volume: 49
  start-page: 228
  year: 2015
  end-page: 233
  article-title: Generalized periodic discharges: Pathophysiology and clinical considerations
  publication-title: Epilepsy Behav.
– volume: 23
  start-page: 966
  year: 2008
  end-page: 970
  article-title: The neurotoxicity and safety of treatment with cefepime in patients with renal failure
  publication-title: Nephrol. Dial. Transplant.
– volume: 17
  start-page: R264
  year: 2013
  article-title: Cefepime neurotoxicity in the intensive care unit: A cause of severe, underappreciated encephalopathy
  publication-title: Crit. Care
– volume: 30
  start-page: 545
  year: 2013
  end-page: 552
  article-title: Neural network modeling of EEG patterns in encephalopathy
  publication-title: J. Clin. Neurophysiol.
– volume: 127
  start-page: 1073
  year: 2016
  end-page: 1080
  article-title: Generalized periodic discharges and “triphasic waves”: A blinded evaluation of inter‐rater agreement and clinical significance
  publication-title: Clin. Neurophysiol.
– volume: 125
  start-page: 255
  year: 2014
  end-page: 262
  article-title: Generalized periodic discharges after acute cerebral ischemia: Reflection of selective synaptic failure?
  publication-title: Clin. Neurophysiol.
– volume: 111
  start-page: 115
  year: 2001
  end-page: 119
  article-title: Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure
  publication-title: Am. J. Med.
– volume: 29
  start-page: 458
  year: 2012
  end-page: 461
  article-title: Comparison of triphasic waves and epileptic discharges in one patient with genetic epilepsy
  publication-title: J. Clin. Neurophysiol.
– volume: 21
  start-page: 276
  year: 2017
  article-title: Cefepime‐induced neurotoxicity: A systematic review
  publication-title: Crit. Care
– volume: 10
  start-page: 405
  year: 1981
  end-page: 410
  article-title: Virus‐induced electrotonic coupling: Hypothesis on the mechanism of periodic EEG discharges in Creutzfelt‐Jakob disease
  publication-title: Ann. Neurol.
– volume: 50
  start-page: 92
  year: 2010
  end-page: 97
  article-title: A case of immune‐mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti‐glutamic acid decarboxylase antibody
  publication-title: Clin. Neurol.
– volume: 45
  start-page: 304
  year: 2003
  end-page: 314
  article-title: Evidence for the involvement of GABAA receptor blockade in convulsions induced by cephalosporins
  publication-title: Neuropharmacology
– volume: 63
  start-page: 279
  year: 1997
  end-page: 293
  article-title: Neurology and the liver
  publication-title: J. Neurol. Neurosurg. Psychiatry
– volume: 128
  start-page: 1682
  year: 2017
  end-page: 1695
  article-title: Synaptic damage underlies EEG abnormalities in postanoxic encephalopathy: A computational study
  publication-title: Clin. Neurophysiol.
– volume: 10
  start-page: 347
  year: 2009
  end-page: 351
  article-title: Cefepime‐induced nonconvulsive status epilepticus: Case report and review
  publication-title: Neurocrit. Care
– volume: 82
  start-page: 549
  year: 2017
  end-page: 559
  article-title: Somatostatin‐positive gamma‐aminobutyric acid interneuron deficits in depression: Cortical microcircuit and therapeutic perspectives
  publication-title: Biol. Psychiatry
– volume: 42
  start-page: 1843
  year: 2008
  end-page: 1850
  article-title: Cephalosporin‐induced neurotoxicity: Clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring
  publication-title: Ann. Pharmacother.
– volume: 18
  start-page: 351
  year: 2015
  end-page: 359
  article-title: Microcircuits and their interactions in epilepsy: Is the focus out of focus?
  publication-title: Nat. Neurosci.
– volume: 23
  start-page: 9664
  year: 2003
  end-page: 9674
  article-title: Major differences in inhibitory synaptic transmission onto two neocortical interneuron subclasses
  publication-title: J. Neurosci.
– volume: 85
  start-page: 1332
  year: 2015
  end-page: 1341
  article-title: Seizures as adverse events of antibiotic drugs: A systematic review
  publication-title: Neurology
– volume: 54
  start-page: 2153
  year: 2000
  end-page: 2155
  article-title: Status epilepticus associated with cefepime
  publication-title: Neurology
– volume: 13
  start-page: 67
  year: 2002
  end-page: 113
  article-title: A spatially continuous mean field theory of electrocortical activity
  publication-title: Network: Comput. Neural Syst.
– volume: 8
  start-page: 40
  year: 2017
  end-page: 43
  article-title: Cefepime induced neurotoxicity: A case series and review of the literature
  publication-title: eNeurologicalSci
– volume: 86
  start-page: 963
  year: 2016
  end-page: 971
  article-title: Antibiotic‐associated encephalopathy
  publication-title: Neurology
– volume: 46
  start-page: 1550
  year: 2005
  end-page: 1552
  article-title: Cephalosporin‐induced nonconvulsive status epilepticus: Clinical and electroencephalographic features
  publication-title: Epilepsia
– ident: e_1_2_8_19_1
  doi: 10.1016/j.ensci.2017.08.001
– ident: e_1_2_8_11_1
  doi: 10.1016/S0002-9343(01)00767-7
– ident: e_1_2_8_20_1
  doi: 10.1002/ana.410100502
– ident: e_1_2_8_23_1
  doi: 10.1186/s13054-017-1856-1
– ident: e_1_2_8_8_1
  doi: 10.1016/j.clinph.2017.06.245
– ident: e_1_2_8_21_1
  doi: 10.1016/j.clinph.2015.07.018
– ident: e_1_2_8_27_1
  doi: 10.1146/annurev-pharmtox-010611-134636
– ident: e_1_2_8_9_1
  doi: 10.1097/WNP.0b013e3182a73e16
– ident: e_1_2_8_15_1
  doi: 10.1038/44579
– ident: e_1_2_8_14_1
  doi: 10.1007/s12028-008-9166-8
– ident: e_1_2_8_25_1
  doi: 10.1212/WNL.0000000000002023
– ident: e_1_2_8_26_1
  doi: 10.1097/WNP.0b013e31826bde70
– ident: e_1_2_8_18_1
  doi: 10.1093/ndt/gfm713
– ident: e_1_2_8_28_1
  doi: 10.1136/jnnp.63.3.279
– ident: e_1_2_8_30_1
  doi: 10.1038/nn.3950
– ident: e_1_2_8_4_1
  doi: 10.1186/cc13094
– ident: e_1_2_8_10_1
  doi: 10.1016/S0987-7053(00)00234-3
– ident: e_1_2_8_33_1
  doi: 10.1016/j.expneurol.2016.05.037
– ident: e_1_2_8_13_1
  doi: 10.1345/aph.1L307
– ident: e_1_2_8_16_1
  doi: 10.1523/JNEUROSCI.23-29-09664.2003
– volume: 50
  start-page: 92
  year: 2010
  ident: e_1_2_8_31_1
  article-title: A case of immune‐mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti‐glutamic acid decarboxylase antibody
  publication-title: Clin. Neurol.
  contributor:
    fullname: Kobayakawa Y
– ident: e_1_2_8_7_1
  doi: 10.1016/j.clinph.2013.08.005
– ident: e_1_2_8_2_1
  doi: 10.1212/WNL.0000000000002455
– ident: e_1_2_8_3_1
  doi: 10.1016/S0028-3908(03)00188-6
– ident: e_1_2_8_17_1
  doi: 10.1212/WNL.54.11.2153
– ident: e_1_2_8_24_1
  doi: 10.1592/phco.23.3.369.32100
– ident: e_1_2_8_6_1
  doi: 10.1080/net.13.1.67.113
– volume: 52
  start-page: 356
  year: 2012
  ident: e_1_2_8_22_1
  article-title: Severely abnormal electroencephalogram in two patients who were treated with cefepime
  publication-title: Clin. Neurol.
  contributor:
    fullname: Shirota Y
– ident: e_1_2_8_12_1
  doi: 10.1111/j.1528-1167.2005.16305.x
– ident: e_1_2_8_32_1
  doi: 10.1530/EDM-17-0010
– ident: e_1_2_8_29_1
  doi: 10.1016/j.biopsych.2017.05.024
– ident: e_1_2_8_5_1
  doi: 10.1016/j.yebeh.2015.04.007
– ident: e_1_2_8_34_1
SSID ssj0003361
Score 2.2802205
Snippet Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed...
Cefepime, a fourth-generation cephalosporin, acts as a GABA receptor antagonist. Cefepime-induced encephalopathy (CIE) is frequently overlooked. We aimed to...
Aim Cefepime, a fourth‐generation cephalosporin, acts as a GABA A receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed...
AimCefepime, a fourth‐generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime‐induced encephalopathy (CIE) is frequently overlooked. We aimed...
AIMCefepime, a fourth-generation cephalosporin, acts as a GABAA receptor antagonist. Cefepime-induced encephalopathy (CIE) is frequently overlooked. We aimed...
SourceID pubmedcentral
proquest
crossref
pubmed
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 34
SubjectTerms Cefepime
computer simulation
EEG
Electroencephalography
Encephalopathy
Firing pattern
GABAergic neurons
Interneurons
non‐convulsive status epilepticus
Pain
Regular
γ-Aminobutyric acid A receptors
Title Cefepime‐induced encephalopathy: Neural mass modeling of triphasic wave‐like generalized periodic discharges with a high negative component (Tri‐HNC)
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fpcn.12795
https://www.ncbi.nlm.nih.gov/pubmed/30375126
https://www.proquest.com/docview/2163026920
https://search.proquest.com/docview/2127199275
https://pubmed.ncbi.nlm.nih.gov/PMC7379539
Volume 73
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKD4gL_9BAqQziUA5Zre3YieGEFqoVUlcVaqUekCLbcbpR22TV3QXRE4_AnbfjSZhxkqVLhYS4RYozduwZ-xt7_A0hLw0rhE68jIW2ZZz4zMUwzDJWzrtMM-t8OC7Yn6jxUfLhWB5vkDf9XZiWH2K14YaWEeZrNHBj51eMfObqAeOpxgvmTKQYzvXu42_qKCFU52yJmAmmOlYhjOJZfbm-Fl0DmNfjJK_i17AA7d0hn_qmt3Enp4Plwg7c5R-sjv_5b3fJ7Q6Y0retJt0jG76-T27ud0fvD8iPkS_9rDr3P799Bz8eNKKgOCvMpuaswbzGX19TZPoAGecAyGlIsQPrIm1KuoCZaWpAH-gX8xkFnFWnnp60jNfVJUhCvuUGqqJ4SxjJm_yc4hYxNRQJlWntTwJDOcUQ-KaGnqK7hxcViBpPRq8ekqO994ejcdxldogdADwZ61Io77RRRgO8gcXTiZQnKiskd44pXnLLpEduOj7MTCmclxaxpxjyAuYYJh6RzRoq2yK09FlRGpsJzMJkuTaidCaVVkpwlmxWRORFP8b5rCXwyHvHB7o5D90cke1-9PPOhuc5Z1if0nwYkeer12B9eKRiat8ssQxPMYA3BRGPW2VZ1SIwvTDjKiLpmhqtCiCz9_qbupoGhu9UQKOEjshu0JK_Nzw_GE3Cw5N_L_qU3ALUp9t9pG2yubhY-meArBZ2h9zgycFOMKRfBnQmSA
link.rule.ids 230,315,783,787,888,1378,11574,27936,27937,46064,46306,46488,46730
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKkYBL-YeUAgZxKIes1vbaiREXtFAt0F0htJV6QZHjON2obbJqd0H0xCNw5-14EmacH7pUSIhbJDtjx56xv7En3xDyzLBM6IGTodBpHg5cbEOYZhkq62ysWWqdvy4YT9Rob_BuX-6vkZftvzA1P0R34IaW4ddrNHA8kD5n5XNb9hiPtLxELoO5C0zc8Prjb_IoIVTjbomQCaYaXiGM4-leXd2NLkDMi5GS5xGs34J2rpNPbefryJPD3nKR9uzZH7yO__t1N8hGg03pq1qZbpI1V94iV8bN7ftt8mPocjcvjt3Pb9_BlQelyCguDPOZOaowtfHXFxTJPkDGMWBy6rPswNZIq5wuYHGaGVAJ-sV8RgFHxaGjBzXpdXEGkpByuYKmKP4ojPxN7pTiKTE1FDmVaekOPEk5xSj4qoShotvTkwJEjSbD53fI3s6b6XAUNskdQgsYT4Y6F8pZbZTRgHBg_7Qi4gMVZ5JbyxTPecqkQ3o63o9NLqyTKcJP0ecZLDNM3CXrJTR2n9DcxVlu0lhgIqaUayNyayKZSgn-UhpnAXnaTnIyrzk8ktb3gWFO_DAHZKud_qQx49OEM2xPad4PyJOuGAwQb1VM6aol1uERxvBGIOJerS1dKwIzDDOuAhKt6FFXAcm9V0vKYuZJviMBnRI6INteTf7e8eTDcOIfNv-96mNydTQd7ya7byfvH5BrAAJ1fay0RdYXJ0v3EIDWIn3k7ekXPOwpiQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKkSouvB8LBQziUA5Zre3YieGEFlbLo6sKtVIPSJHtON2obRK1uyB64idw59_xS5jJiy4VEuIWyc7YsWfsb-zJN4Q8MywVOvQyENpmQehjF8A0y0A572LNrPP1dcH2TE33wnf7cn-NvOz-hWn4IfoDN7SMer1GA6_S7JyRV64YMh5peYlcDhUgX0REH39zRwmhWm9LBEww1dIKYRhP_-rqZnQBYV4MlDwPYOsdaHKNfOr63gSeHA6XCzt0Z3_QOv7nx10nV1tkSl81qnSDrPniJtnYbu_eb5EfY5_5Kj_2P799B0ceVCKluCxUc3NUYmLjry8oUn2AjGNA5LTOsQMbIy0zuoClaW5AIegX8xkFHOWHnh40lNf5GUhCwuUSmqL4mzCyN_lTimfE1FBkVKaFP6gpyinGwJcFjBTd2j3JQdR0Nn5-m-xN3uyOp0Gb2iFwgPBkoDOhvNNGGQ34BnZPJyIeqjiV3DmmeMYtkx7J6fgoNplwXloEn2LEU1hkmLhD1gto7B6hmY_TzNhYYBomy7URmTORtFKCt2TjdECednOcVA2DR9J5PjDMST3MA7LZzX7SGvFpwhm2pzQfDciTvhjMD-9UTOHLJdbhEUbwRiDibqMsfSsC8wszrgYkWlGjvgJSe6-WFPm8pviOBHRK6AHZqrXk7x1Pdsaz-uH-v1d9TDZ2Xk-SD29n7x-QK4AAdXOmtEnWFydL_xBQ1sI-qq3pF7ZeKDg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cefepime%E2%80%90induced+encephalopathy%3A+Neural+mass+modeling+of+triphasic+wave%E2%80%90like+generalized+periodic+discharges+with+a+high+negative+component+%28Tri%E2%80%90HNC%29&rft.jtitle=Psychiatry+and+clinical+neurosciences&rft.au=Tamune%2C+Hidetaka&rft.au=Hamamoto%2C+Yu&rft.au=Aso%2C+Naofumi&rft.au=Yamamoto%2C+Naoki&rft.date=2019-01-01&rft.pub=John+Wiley+%26+Sons+Australia%2C+Ltd&rft.issn=1323-1316&rft.eissn=1440-1819&rft.volume=73&rft.issue=1&rft.spage=34&rft.epage=42&rft_id=info:doi/10.1111%2Fpcn.12795&rft.externalDBID=10.1111%252Fpcn.12795&rft.externalDocID=PCN12795
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1323-1316&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1323-1316&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1323-1316&client=summon